ALDH-high signature enriched ovarian clear cell carcinoma correlates with advanced disease, poor patient outcomes, and unique immune profiles

RUBY YUN-JU HUANGTuan Zea TanJieru YeKuee Theng KuayDiana GZ LimJeffrey JH LowMahesh ChoolaniDavid SP Tan2020-07-052020-07-052017-03https://scholars.lib.ntu.edu.tw/handle/123456789/508936Course: SIS2 Special Interest Session II: Contemporary Issues in Gynecologic Oncology: An International Focus Session Type: Special Interest Session Day: Saturday, March 11, 2017ALDH-high signature enriched ovarian clear cell carcinoma correlates with advanced disease, poor patient outcomes, and unique immune profilesother